Anirvan Ghosh - 18 Nov 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Anirvan Ghosh
Issuer symbol
UBX
Transactions as of
18 Nov 2022
Transactions value $
$0
Form type
4
Filing time
21 Nov 2022, 16:35:28 UTC
Previous filing
04 Nov 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +200K $0.00 200K 18 Nov 2022 Common Stock 200K $2.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares vest and become exercisable pursuant to the following schedule: One-eighth of the shares subject to the option vest in successive, equal quarterly installments starting on February 18, 2023, subject to the Reporting Person's continued service to Issuer through the applicable vesting date.